Header Logo

Connection

Ian Dunn to Brain Neoplasms

Back to Details
This is a "connection" page, showing publications Ian Dunn has written about Brain Neoplasms.
Ian Dunn
Connection Strength
11.369
Brain Neoplasms
  1. Primary versus secondary gliosarcoma: a systematic review and meta-analysis. J Neurooncol. 2022 Aug; 159(1):195-200.
    View in: PubMed
    Score: 0.628
  2. The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age. J Neurooncol. 2022 Jul; 158(3):405-412.
    View in: PubMed
    Score: 0.623
  3. The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas. Cancer. 2022 05 15; 128(10):1907-1912.
    View in: PubMed
    Score: 0.613
  4. H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients. J Neurooncol. 2021 Dec; 155(3):225-234.
    View in: PubMed
    Score: 0.602
  5. The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis. BMC Cancer. 2020 Sep 21; 20(1):897.
    View in: PubMed
    Score: 0.555
  6. Venous Thromboembolism Prophylaxis: Safe, but Still Provocative? Thromb Haemost. 2019 11; 119(11):1716-1718.
    View in: PubMed
    Score: 0.522
  7. High-grade meningiomas: biology and implications. Neurosurg Focus. 2018 04; 44(4):E2.
    View in: PubMed
    Score: 0.468
  8. Unplanned Reoperation After Craniotomy for Tumor: A National Surgical Quality Improvement Program Analysis. Neurosurgery. 2017 Nov 01; 81(5):761-771.
    View in: PubMed
    Score: 0.455
  9. Readmission After Craniotomy for Tumor: A National Surgical Quality Improvement Program Analysis. Neurosurgery. 2017 04 01; 80(4):551-562.
    View in: PubMed
    Score: 0.437
  10. Landscape of Genomic Alterations in Pituitary Adenomas. Clin Cancer Res. 2017 Apr 01; 23(7):1841-1851.
    View in: PubMed
    Score: 0.422
  11. Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis. Cancer. 2016 Jun 01; 122(11):1708-17.
    View in: PubMed
    Score: 0.406
  12. Genomic landscape of intracranial meningiomas. J Neurosurg. 2016 09; 125(3):525-35.
    View in: PubMed
    Score: 0.401
  13. Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. Neurosurg Focus. 2015 Dec; 39(6):E12.
    View in: PubMed
    Score: 0.398
  14. "Extraoperative" MRI (eoMRI) for Brain Tumor Surgery: Initial Results at a Single Institution. World Neurosurg. 2015 Jun; 83(6):921-8.
    View in: PubMed
    Score: 0.377
  15. A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity. Proc Natl Acad Sci U S A. 2025 May 06; 122(18):e2427073122.
    View in: PubMed
    Score: 0.191
  16. Mask-based vs. frame-based stereotactic radiosurgery: A systematic review. J Clin Neurosci. 2025 May; 135:111195.
    View in: PubMed
    Score: 0.190
  17. In Reply to the Letter to the Editor Regarding "Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example". World Neurosurg. 2024 Sep; 189:553.
    View in: PubMed
    Score: 0.183
  18. The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy. Neurosurgery. 2003 Jun; 52(6):1411-22; discussion 1422-4.
    View in: PubMed
    Score: 0.167
  19. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline. J Clin Oncol. 2022 07 10; 40(20):2271-2276.
    View in: PubMed
    Score: 0.156
  20. Physical Forces in Glioblastoma Migration: A Systematic Review. Int J Mol Sci. 2022 Apr 06; 23(7).
    View in: PubMed
    Score: 0.154
  21. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol. 2022 02 10; 40(5):492-516.
    View in: PubMed
    Score: 0.151
  22. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Sci Rep. 2021 09 09; 11(1):18009.
    View in: PubMed
    Score: 0.148
  23. Clinical significance of checkpoint regulator "Programmed death ligand-1 (PD-L1)" expression in meningioma: review of the current status. J Neurooncol. 2021 Feb; 151(3):443-449.
    View in: PubMed
    Score: 0.143
  24. Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol. 2000 Oct-Nov; 50(1-2):121-37.
    View in: PubMed
    Score: 0.139
  25. GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors. Sci Rep. 2020 06 03; 10(1):9027.
    View in: PubMed
    Score: 0.136
  26. Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022. Clin Breast Cancer. 2020 04; 20(2):145-151.e2.
    View in: PubMed
    Score: 0.129
  27. Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial. J Clin Oncol. 2019 03 20; 37(9):741-750.
    View in: PubMed
    Score: 0.124
  28. Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis. World Neurosurg. 2019 Feb; 122:e1557-e1561.
    View in: PubMed
    Score: 0.122
  29. Clinical applications of dynamic CT angiography for intracranial lesions. Acta Neurochir (Wien). 2018 04; 160(4):675-680.
    View in: PubMed
    Score: 0.115
  30. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. 2017 Oct 19; 19(11):1511-1521.
    View in: PubMed
    Score: 0.113
  31. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. J Neurooncol. 2017 Dec; 135(3):581-591.
    View in: PubMed
    Score: 0.113
  32. Updates in the management of brain metastases. Neuro Oncol. 2016 08; 18(8):1043-65.
    View in: PubMed
    Score: 0.104
  33. Genomic characterization of recurrent high-grade astroblastoma. Cancer Genet. 2016 Jul-Aug; 209(7-8):321-30.
    View in: PubMed
    Score: 0.103
  34. High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathol. 2016 Jul; 33(3):222-7.
    View in: PubMed
    Score: 0.101
  35. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov. 2015 Nov; 5(11):1164-1177.
    View in: PubMed
    Score: 0.098
  36. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases. J Neurooncol. 2015 Sep; 124(3):429-37.
    View in: PubMed
    Score: 0.097
  37. Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation. J Neurooncol. 2015 Aug; 124(1):137-46.
    View in: PubMed
    Score: 0.096
  38. Extracranial growth of glioblastoma multiforme. J Clin Neurosci. 2015 Sep; 22(9):1521-3.
    View in: PubMed
    Score: 0.096
  39. Recurrent radiation necrosis in the brain following stereotactic radiosurgery. Pract Radiat Oncol. 2015 May-Jun; 5(3):e151-e154.
    View in: PubMed
    Score: 0.096
  40. Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):384-9.
    View in: PubMed
    Score: 0.095
  41. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro Oncol. 2015 Oct; 17(10):1344-55.
    View in: PubMed
    Score: 0.095
  42. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget. 2014 Sep 30; 5(18):8083-92.
    View in: PubMed
    Score: 0.092
  43. Local control after fractionated stereotactic radiation therapy for brain metastases. J Neurooncol. 2014 Nov; 120(2):339-46.
    View in: PubMed
    Score: 0.091
  44. Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery. Proc Natl Acad Sci U S A. 2014 Jul 29; 111(30):11121-6.
    View in: PubMed
    Score: 0.090
  45. Mass spectrometry imaging as a tool for surgical decision-making. J Mass Spectrom. 2013 Nov; 48(11):1178-87.
    View in: PubMed
    Score: 0.086
  46. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci U S A. 2013 May 14; 110(20):8188-93.
    View in: PubMed
    Score: 0.083
  47. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013 Mar; 45(3):285-9.
    View in: PubMed
    Score: 0.082
  48. Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proc Natl Acad Sci U S A. 2013 Jan 29; 110(5):1611-6.
    View in: PubMed
    Score: 0.081
  49. Patterns in neurosurgical adverse events: intracranial neoplasm surgery. Neurosurg Focus. 2012 Nov; 33(5):E16.
    View in: PubMed
    Score: 0.080
  50. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 2012 Apr 15; 26(8):756-84.
    View in: PubMed
    Score: 0.077
  51. Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide. Clin Neurol Neurosurg. 2010 Oct; 112(8):741-2.
    View in: PubMed
    Score: 0.070
  52. Genomics of human glioblastoma multiforme: a glimpse of the future. Neurosurgery. 2008 Dec; 63(6):15.
    View in: PubMed
    Score: 0.061
  53. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol. 2001 Jan; 19(1):35-9.
    View in: PubMed
    Score: 0.035
  54. Assessment of alterations in gene expression in recurrent malignant glioma after radiotherapy using complementary deoxyribonucleic acid microarrays. Neurosurgery. 2001 Jan; 48(1):195-201; discussion 201-2.
    View in: PubMed
    Score: 0.035
  55. Incidence, risk factors and management of severe post-transsphenoidal epistaxis. J Clin Neurosci. 2015 Jan; 22(1):116-22.
    View in: PubMed
    Score: 0.023
  56. Craniectomy-associated Progressive Extra-Axial Collections with Treated Hydrocephalus (CAPECTH): redefining a common complication of decompressive craniectomy. J Clin Neurosci. 2012 Sep; 19(9):1222-7.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.